COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Clinical trial NCT04724642 · UNKNOWN

Trial details

NCT number: NCT04724642
Sponsor: Tel-Aviv Sourasky Medical Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Allogenic Hematopoietic Cell Transplant CAR-T Therapy Primary Immunodeficiency

Start date: 2020-12-28
Primary completion: 2021-05-28
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.